Interferon beta-1a and atorvastatin combination therapy: 12-month results from an open-label, randomized, clinical study

被引：0
|
作者：
Orefice, Giuseppe
Quarantelli, Mario
Salvatore, Petronilla
Brunetti, Arturo
Lanzillo, Roberta
Prinster, Anna
Vacca, Giovanni
Mollica, Carmine
Bonauita, Vincenzo
Morra, Vincenzo Brescia
机构：
来源：
NEUROLOGY | 2008年 / 70卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A85 / A85
页数：1
相关论文
共 50 条
  • [1] Is brain atrophy progression in RR-MS slowed by the association off atorvastatin and interferon beta-1a? Preliminary results from an open-label, randomized, clinical study
    Quarantelli, Mario
    Orefice, Giuseppe
    Prinster, Anna
    Lanzillo, Roberta
    Salvatore, Petronilla
    Mallica, Carmine
    Salvatore, Elena
    Brunetti, Arturo
    Alfano, Bruno
    Morra, Vincenzo Brescia
    [J]. NEUROLOGY, 2008, 70 (11) : A84 - A85
  • [2] An open label randomised clinical trial of atorvastatin in combination with IFN beta-1a in active MS patients: 12 months results
    Orefice, G.
    Quarantelli, M.
    Salvatore, P.
    Brunetti, A.
    Lanzillo, R.
    Prinster, A.
    Vacca, G.
    Mollica, C.
    Bonavita, V.
    Morra, V. Brescia
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S56 - S57
  • [3] Combination therapy with intramuscular interferon beta-1a and oral doxycycline in patients with multiple sclerosis: An open-label trial
    Minagar, A
    Alexander, JS
    Brooks, R
    Kelley, RE
    Schwendimann, RN
    Gonzalez-Toledo, E
    Bryan, DM
    [J]. NEUROLOGY, 2006, 66 (05) : A34 - A34
  • [4] An open-label trial of combination therapy with intramuscular interferon beta-1a and oral doxycycline in patients with multiple sclerosis
    Minagar, A
    Alexander, JS
    Brooks, R
    Kelley, RE
    Gonzalez-Toledo, E
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S79 - S79
  • [5] Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study
    Kowalzick, L
    Rogozinski, T
    Wimheuer, R
    Pilz, J
    Manske, U
    Scholz, A
    Fierlbeck, G
    Mohr, P
    Ochsendorf, F
    Wagner, G
    Gaus, W
    Brzoska, J
    Jablonska, S
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2002, 12 (06) : 558 - 561
  • [6] FELBAMATE IN THE TREATMENT OF LENNOX-GASTAUT SYNDROME - RESULTS OF A 12-MONTH OPEN-LABEL STUDY FOLLOWING A RANDOMIZED CLINICAL-TRIAL
    DODSON, WE
    [J]. EPILEPSIA, 1993, 34 : S18 - S24
  • [7] Frovatriptan for the prevention of menstrual migraine headaches: Results of a 12-month open-label safety and tolerability study
    Gammaitoni, A
    Ford, C
    Tobin, J
    Shaw, R
    Campbell, J
    [J]. NEUROLOGY, 2006, 66 (05) : A224 - A224
  • [8] Atorvastatin combined with interfereon beta 1a in relapsing-remitting multiple sclerosis: preliminary results of a 24 month randomized open-label clinical trial
    Oztekin, Nese S.
    Oztekin, Favzi M.
    Munis, Oezlem B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S171 - S171
  • [9] Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis
    Rieckmann, Peter
    Heidenreich, Fedor
    Sailer, Michael
    Zettl, Uwe K.
    Zessack, Norbert
    Hartung, Hans-Peter
    Gold, Ralf
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2012, 5 (01) : 3 - 12
  • [10] DEGARELIX VERSUS LEUPROLIDE DEPOT (7.5 MG): RESULTS FROM A 12-MONTH, RANDOMIZED, OPEN-LABEL, PHASE III STUDY IN PATIENTS WITH PROSTATE CANCER
    Persson, B. E.
    Boccon-Gibod, L.
    Klotz, L.
    Schroder, F. H.
    Andreou, C.
    Cantor, P.
    Jensen, J. K.
    Olesen, T. K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S318 - S318
12345